| Category | BioTech |
| Phone | 514-282-9990 |
| Employees | |
| Founded | 2000 |
| TOTAL | $12.2M |
| VENTURE FUNDING TOTAL | $12.2M |
| Series B, 5/05 T2C2 Capital Solidarity Fund QFL Desjardins Venture Capital Lothian Partners | $12.2M |
BioAxone Therapeutic operates as a neuroscience company. The company specializes in the development and commercialization of proprietary technologies that target Rho signaling. It provides an experimental therapy for the treatment of neurological disorders. The company’s product includes Cethrin for clinical trial for spinal cord injury. BioAxone Therapeutic was founded in 2000 and is based in Saint-Laurent, Canada.
